The FDA has approved an expanded indication for the CD3-directed monoclonal antibody teplizumab-mzwv to delay stage 3 type 1 ...

The expanded approval was based on the single-arm, non-randomized, open-label phase 4 PETITE-T1D study, which evaluated the safety and pharmacokinetics of teplizumab.

Teplizumab now indicated for kids as young as 1 year with preclinical disease ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

The early recognition of type 1 diabetes in a toddler with increased thirst, lethargy, vision difficulties, and fruity breath ...

Add Yahoo as a preferred source to see more of our stories on Google. Baricitinib, a pill typically prescribed for rheumatoid arthritis and alopecia, might help slow the progression of type 1 diabetes ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

Oct. 31, 2024 -- Type 1 diabetes can develop at any age, making early screening crucial for those at risk. But how do we know who is at risk? When should we screen? And what steps can we take to ...

Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...